On the other hand, the wide potential of this natural compound, its low price, and its excellent tolerance in humans, are strong incentives to further characterize its effects, especially for possible applications in diseases with few treatments to date, such as CPT2 or VLCAD deficiency. Here, CPT2 is linked to very long chain acyl-CoA dehydrogenase deficiency.